1-110112820-C-G

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_203412.2(UBL4B):​c.286C>G​(p.Leu96Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)

Consequence

UBL4B
NM_203412.2 missense

Scores

19

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.43
Variant links:
Genes affected
UBL4B (HGNC:32309): (ubiquitin like 4B) Involved in positive regulation of protein targeting to mitochondrion. Predicted to be located in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.04546264).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
UBL4BNM_203412.2 linkc.286C>G p.Leu96Val missense_variant Exon 1 of 1 ENST00000334179.5 NP_981957.1 Q8N7F7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
UBL4BENST00000334179.5 linkc.286C>G p.Leu96Val missense_variant Exon 1 of 1 6 NM_203412.2 ENSP00000334044.3 Q8N7F7

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Dec 16, 2023
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.286C>G (p.L96V) alteration is located in exon 1 (coding exon 1) of the UBL4B gene. This alteration results from a C to G substitution at nucleotide position 286, causing the leucine (L) at amino acid position 96 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.078
BayesDel_addAF
Benign
-0.22
T
BayesDel_noAF
Benign
-0.56
CADD
Benign
7.7
DANN
Benign
0.89
DEOGEN2
Benign
0.0062
T
Eigen
Benign
-0.88
Eigen_PC
Benign
-0.90
FATHMM_MKL
Benign
0.16
N
LIST_S2
Benign
0.36
T
M_CAP
Benign
0.0054
T
MetaRNN
Benign
0.045
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.69
N
PrimateAI
Benign
0.20
T
PROVEAN
Benign
0.080
N
REVEL
Benign
0.030
Sift
Benign
0.11
T
Sift4G
Benign
0.16
T
Polyphen
0.0040
B
Vest4
0.023
MutPred
0.34
Gain of methylation at K100 (P = 0.0657);
MVP
0.12
MPC
0.080
ClinPred
0.057
T
GERP RS
2.4
Varity_R
0.081
gMVP
0.12

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr1-110655442; API